|
negative regulation of metabolic process
|
GO_0009892 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism.] |
|
Decreased T cell apoptosis
|
HP_0002731 |
[Abnormal decrease of apoptosis by peripheral blood T cells in an in vitro culture, compared to a healthy control sample. May be either spontaneous, induced by UV, X-ray, FasL or other agens. Commonly measured by surface expression of phosphatidyl serine labelled by Annexin V, but other methods such as staning of cleaved Caspases may be used by different laboratories.] |
|
Abnormal T cell apoptosis
|
HP_0030886 |
[Abnormal apoptosis by peripheral blood T cells in an in vitro culture, compared to a healthy control sample. May be either spontaneous, induced by UV, X-ray, FasL or other agens. Commonly measured by surface expression of phosphatidyl serine labelled by Annexin V, but other methods such as staning of cleaved Caspases may be used by different laboratories.] |
|
regulation of metabolic process
|
GO_0019222 |
[Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism.] |
|
regulation of hormone levels
|
GO_0010817 |
[Any process that modulates the levels of hormone within an organism or a tissue. A hormone is any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action.] |
|
negative regulation of hormone biosynthetic process
|
GO_0032353 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones.] |
|
regulation of hormone biosynthetic process
|
GO_0046885 |
[Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones.] |
|
negative regulation of biosynthetic process
|
GO_0009890 |
[Any process that stops, prevents, or reduces the rate of the chemical reactions and pathways resulting in the formation of substances.] |
|
positive regulation of hormone metabolic process
|
GO_0032352 |
[Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving any hormone.] |
|
positive regulation of metabolic process
|
GO_0009893 |
[Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism.] |
|
nervous system development
|
GO_0007399 |
[The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.] |
|
ectoderm development
|
GO_0007398 |
[The process whose specific outcome is the progression of the ectoderm over time, from its formation to the mature structure. In animal embryos, the ectoderm is the outer germ layer of the embryo, formed during gastrulation.] |
|
Chronic noninfectious lymphadenopathy
|
HP_0002730 |
[A chronic form of lymphadenopathy that is not related to infection.] |
|
sarcosine zwitterion
|
CHEBI_57433 |
[An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of sarcosine; major species at pH 7.3.] |
|
N-alkylglycine zwitterion
|
CHEBI_66884 |
[An amino acid zwitterion arising from transfer of a proton from the carboxy to the amino group of any N-alkylglycine; major species at pH 7.3.] |
|
phosphorus oxoanion
|
CHEBI_33461 |
|
|
phosphorus molecular entity
|
CHEBI_26082 |
|
|
pnictogen oxoanion
|
CHEBI_33459 |
|
|
teratoma
|
MPATH_322 |
[Generally benign germ cell derived tumors of male or female containing derivatives from all three germ layers with differentiation in the malignant form being poor. Malignant tumors are highly metatstatic. (M-9080/1).] |
|
liver trabecula
|
UBERON_0010183 |
[A trabecula that is part of a liver.] |